Bonefos and the Consumption of Analgesics

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The effect of Bonefos on consumption of analgesics (drugs used for pain treatment) in patients with proven bone metastases.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Analgesics; Clodronic Acid

Criteria

Inclusion Criteria:

• Breast cancer or prostate cancer or multiple myeloma.

• Bone metastasis.

• Ability to use analgesics and clodronate 1600 mg/day.

Exclusion Criteria:

• Hypersensitivity to bisphosphonates.

• Clodronate in previous therapy.

• Concomitant use of other bisphosphonates.

• Serious renal insufficiency.